{"nct_id":"NCT01533259","title":"Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients","status":"COMPLETED","status_verified_date":"2015-01","start_date":"2012-01","start_date_type":null,"primary_completion_date":"2012-11","primary_completion_date_type":"ACTUAL","completion_date":"2013-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}